JFA
KITE

JNBA Financial Advisors’s Kite Pharma, Inc. KITE Stock Holding History

JNBA Financial Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$6K – 563
2015
Q3 		$6K Hold
100
– – ﹤0.01% 399
2015
Q2 		$6K Hold
100
– – ﹤0.01% 402
2015
Q1 		$6K Buy
+100
New +$6.7K ﹤0.01% 413

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JNBA Financial Advisors's KITE Position: Q4 2015 in Review

JNBA Financial Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2015, closing a stake of 100 shares — an estimated $6K sold.

JNBA Financial Advisors first reported a position in KITE in Q1 2015 and held it in 3 quarters. The position peaked at $6K in Q3 2015. 187 funds tracked by Wall St. Rank hold KITE as of Q4 2015.

  • JNBA Financial Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • JNBA Financial Advisors sold 100 Kite Pharma, Inc. shares in Q4 2015, an estimated $6K.
  • JNBA Financial Advisors first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 3 quarters.
  • JNBA Financial Advisors's Kite Pharma, Inc. position peaked at $6K in Q3 2015.
  • 187 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2015.

Based on JNBA Financial Advisors's 13F filing for Q4 2015, filed 27 Jan 2016.